Learning Outcomes

Principle learning outcomes of the SafeSciMET programme are novel competences in translational safety sciences, leading to a new type of safety scientists who are able to perform a holistic and critical evaluation of the safety of drug candidates and new medicines in context of drug development and usage by evaluating and linking in vitro as well as animal and patient safety data more effectively. They will also assist the implementation of the 3Rs concept thereby reducing the overall use of experimental animals.

Regulatory scientists will become better equipped to judge the safety data and profiles of new and existing medicines. Scientists from academia incl. Eastern-Europe will acquire unique industrial know-how and an integrated understanding of safety aspects and its impact on drug discovery, development and use.